1. Home
  2. MRVI vs CCIR Comparison

MRVI vs CCIR Comparison

Compare MRVI & CCIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • CCIR
  • Stock Information
  • Founded
  • MRVI 2014
  • CCIR 2021
  • Country
  • MRVI United States
  • CCIR United States
  • Employees
  • MRVI N/A
  • CCIR N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • CCIR
  • Sector
  • MRVI Health Care
  • CCIR
  • Exchange
  • MRVI Nasdaq
  • CCIR NYSE
  • Market Cap
  • MRVI 312.4M
  • CCIR 349.1M
  • IPO Year
  • MRVI 2020
  • CCIR 2024
  • Fundamental
  • Price
  • MRVI $2.27
  • CCIR $10.81
  • Analyst Decision
  • MRVI Hold
  • CCIR
  • Analyst Count
  • MRVI 10
  • CCIR 0
  • Target Price
  • MRVI $6.84
  • CCIR N/A
  • AVG Volume (30 Days)
  • MRVI 1.6M
  • CCIR 471.4K
  • Earning Date
  • MRVI 08-06-2025
  • CCIR 01-01-0001
  • Dividend Yield
  • MRVI N/A
  • CCIR N/A
  • EPS Growth
  • MRVI N/A
  • CCIR N/A
  • EPS
  • MRVI N/A
  • CCIR 0.12
  • Revenue
  • MRVI $241,856,000.00
  • CCIR N/A
  • Revenue This Year
  • MRVI N/A
  • CCIR N/A
  • Revenue Next Year
  • MRVI $10.62
  • CCIR N/A
  • P/E Ratio
  • MRVI N/A
  • CCIR $90.00
  • Revenue Growth
  • MRVI N/A
  • CCIR N/A
  • 52 Week Low
  • MRVI $1.67
  • CCIR $9.92
  • 52 Week High
  • MRVI $10.03
  • CCIR $13.35
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 54.46
  • CCIR N/A
  • Support Level
  • MRVI $2.00
  • CCIR N/A
  • Resistance Level
  • MRVI $2.44
  • CCIR N/A
  • Average True Range (ATR)
  • MRVI 0.15
  • CCIR 0.00
  • MACD
  • MRVI -0.00
  • CCIR 0.00
  • Stochastic Oscillator
  • MRVI 61.36
  • CCIR 0.00

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About CCIR COHEN CIRCLE ACQUISITION CORP I

Cohen Circle Acquisition Corp I is a blank check company.

Share on Social Networks: